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ABSTRACT 
Spherical multilammelar vesicles of liposome consisting of lipid egg phosphatidylcholine, soya lecithin and cholesterol were 
prepared by thin film hydration technique. Further liposomal gel was prepared by egg phosphatidylcholine and cholesterol of molar 
ratio 7:3 and attained slow drug release with Allicin- Amphotericin B liposomal based gels as compared to the plane gel. Liposomal 
gel was characterized for drug release kinetics, antifungal activity (disc diffusion assay). Formulation F8 A shows highest drug 
release. Allicin (Allium sativum Linn.) showed a minimum inhibitory concentration (MIC) at the dose range from 0.195 µg/ml to 10 
µg/ml of broth against all fungal strains (F2B Formulation). These lower concentrations were achievable for fungistatic effect and 
the reduced adverse effects. The results suggest that liposomal gel of Amphotericin B may be useful in the treatment of Topical 
Fungal Infections. 
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INTRODUCTION: 
Topical liposome formulations are more effective and 
less toxic than conventional formulations
1
. The type and 
concentration of the polymer, which forms the gel 
matrix, could influence the stability as well as the 
release rate of the incorporated drug
 2
. Fungal infections 
are usually more difficult to treat than bacterial 
infections, because fungal organisms grow slowly and 
because fungal infections often occur in tissues that are 
poorly penetrated by antimicrobial agents. Allicin as 
active constituent of Garlic (Allium sativum Linn.), is a 
bioenhancers capable for improving the bioavailability 
of drug, reducing the dose of Amphotericin B, adverse 
reaction and shorten period of treatment 
3
. Combination 
of Allicin and Amphotericin B show synergistic effect at 
low concentration. Incorporation of Amphotericin B into 
Liposome offers a potential means to reduce the toxicity 
of this antifungal drug 
4
. 
METHODS: 
Preparation of Liposomal gel  
Carbopol (934) 2% w/v was allowed to hydrate for 3-4 
hr. 5 ml of liposomal suspension was added in gel base 
and mix by stirrer. The mixture was stirred until 
thickening and neutralized by the drop wise addition of 
triethanolamine to achieve the homogeneous gel. The 
gel was sonicated for 15 minute and then, kept overnight 
to remove the air bubbles. 
 
Characterization of Liposomal gel 
Drug content in liposomal gel 
Specific quantity of the prepared gel was taken and 
dissolved in 100 ml of phosphate buffer of pH 5.5. 
Volumetric flask containing gel solution was shaken for 
2 hr. on mechanical stirrer, filtered and drug absorbance 
was recorded by UV-visible spectrophotometer at OD 
270 nm using phosphate buffer as blank. 
 
In vitro Drug Release 
Dialysis membrane was employed in two sides open 
ended cylinder. One g of liposomal gel containing 
known amount of drug was placed in a dialysis 
membrane 2 ml of acetonitrile was added to each aliquot 
to precipitate the lipids and dissolve the entrapped 
Amphotericin-B and then the samples were analyzed by 
UV spectrophotometers at a λ max of 270 nm.  
Antifungal Activity 
Sabouraud Dextrose Broth (SDB Liquid Medium) 
Sabouraud Dextrose Agar (SDA Solid Medium) 
Sabouraud Dextrose Broth (Sabouraud Liquid Medium) 
was used for cultivation of yeasts, moulds and fungi 
microorganisms..The sample of strain of Candida 
albicans, Aspergillus niger, Saccharomyces cerevisiae 
were cultured and colony forming units were calculated 
by following formula
5
. 
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Two fold serial dilution and cup fold method were 
implied to test for zone of inhibition. 
 
 
RESULT AND DISCUSSION: 
Surface morphology by Scanning Electron 
microscopy (SEM) 
The samples are examined under scanning electron 
microscope.  
 
Figure 1: Large unilamellar vesicles 
Drug content in liposomal gel 
The formulated liposomal gel was analyzed for 
percentage of drug contents Compared to plane gel. The 
formulation code, F 2 A and F 2 B has showed the 
highest drug content (84.06 ± 0.33 and 87.05 ± 0.0.33).  
 
Figure 2: Drug content of liposomal gel ± S.D. mean 
(n=3) 
 
In vitro drug release- Formulation F8 shows high drug 
release after plane gel. 
 
Figure 3: Drug release of liposomal gel (A) ± S.D. mean (n=3). 
Antifungal Activity 
The result revealed that the Allicin (Allium sativum 
Linn.) showed a minimum inhibitory concentration 
(MIC) at the dose range from 0.195 µg/ml to 10 µg/ml 
of broth against all fungal strains. The lowest activity 
was found with F7A and the greatest activity was found 
with F2B. 
 
Figure 4: Antifungal activity 
CONCLUSION: 
Amphotericin B can be successfully incorporated into 
the liposomal gel formulations. The use of Allicin 
increase bioavailability and potential to minimize its 
dose related Adverse Effect of Amphotericin B. Allicin 
loaded liposomes provide a control release of 
Amphotericin B. This is due to the robustness and rigid 
nature of the egg phosphatidylcholine when compared to 
the soya-lecithin and cholesterol. The liposomal gel 
shows promising results for targeting of antifungal 
drugs.  
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